SXI Stock Analysis: Standex International | NYSE

Electronic Sensors, Hydraulic Cylinders, Refrigeration Equipment, Mold Engraving

Total Rating 66

Safety 82

Buy Signal -0.22

Specialty Industrial Machinery
Industry Rotation: +8.7

Market Cap: 3.22B
Avg Turnover: 34.4M

Risk 3d forecast

Volatility32.2%

VaR 5^th Pctl5.56%

VaR vs Median5.00%

Reward TTM

Sharpe Ratio0.95

Rel. Str. IBD52.4

Rel. Str. Peer Group61.9

Character TTM

Beta1.608

Beta Downside1.464

Hurst Exponent0.500

Drawdowns 3y

Max DD38.01%

CAGR/Max DD0.67

CAGR/Mean DD2.85

EPS (Earnings per Share)

EPS CAGR: 9.92%
EPS Trend: 95.0%

Last SUE: 1.24
Qual. Beats: 1

Revenue

Rev. CAGR: 8.74%
Rev. Trend: 85.7%

Last SUE: 0.33
Qual. Beats: 0

Warnings

Below Avwap Earnings

Tailwinds

No distinct edge detected

Seasonality 11.7 years of data

Jan -0.2% 16

Feb +3.8% 35

Mar -5.1% 20

Apr -4.4% 34

May +0.7% 26

Jun +0.4% 5

Jul +0.6% 10

Aug -0.8% 11

Sep +0.6% 11

Oct +2.1% 17

Nov +1.9% 23

Dec +0.3% 13

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: SXI Standex International

Standex International Corporation (NYSE: SXI) is a diversified industrial manufacturer founded in 1955 and headquartered in Salem, New Hampshire. The company operates through five reporting segments-Electronics, Engineering Technologies, Scientific, Engraving, and Specialty Solutions-serving commercial and industrial markets in the United States and internationally.

Its product portfolio spans a wide range of niche industrial applications, including reed relays, custom electronic sensors, and transformers (marketed under brands such as Standex-Meder, Renco, and Agile Magnetics); mold texturizing and engraving tooling (Piazza Rosa, GS Engineering, Innovent); specialty temperature-controlled equipment for medical, scientific, and pharmaceutical use (American BioTech Supply, Lab Research Products, Cryosafe); net and near-net formed metal components for aerospace, defense, and energy markets (Spincraft, McStarlite); and hydraulic cylinders for trucks and specialty vehicles (Federal, Custom Hoist).

The company is classified within the Industrials sector under the GICS Industrial Machinery & Supplies & Components sub-industry, reflecting its profile as a multi-segment industrial products business serving diversified end markets. Standex uses a multi-brand strategy, with each segment operating under several legacy brand names acquired over time, and serves a broad customer base across aviation, aerospace, defense, energy, medical, and industrial sectors.

Headlines to Watch Out For

Electronics segment margins pressured by component costs and pricing
Aerospace and defense backlog growth lifts Engineering Technologies revenue
Scientific segment normalizes after pandemic-era refrigeration demand surge

Piotroski VR-10 (Strict) 7.5

Net Income: 104.6m TTM > 0 and > 6% of Revenue
FCF/TA: 0.03 > 0.02 and ΔFCF/TA 0.53 > 1.0
NWC/Revenue: 36.14% < 20% (prev 39.73%; Δ -3.59% < -1%)
CFO/TA 0.06 > 3% & CFO 89.5m > Net Income 104.6m
Net Debt (423.4m) to EBITDA (232.3m): 1.82 < 3
Current Ratio: 2.40 > 1.5 & < 3
Outstanding Shares: last quarter (12.1m) vs 12m ago -0.05% < -2%
Gross Margin: 41.73% > 18% (prev 39.31%; Δ 2.42% > 0.5%)
Asset Turnover: 56.56% > 50% (prev 50.43%; Δ 6.14% > 0%)
Interest Coverage Ratio: 6.31 > 6 (EBIT TTM 193.7m / Interest Expense TTM 30.7m)

Altman Z'' 5.61

A: 0.20 (Total Current Assets 551.8m - Total Current Liabilities 229.5m) / Total Assets 1.59b
B: 0.77 (Retained Earnings 1.22b / Total Assets 1.59b)
C: 0.12 (EBIT TTM 193.7m / Avg Total Assets 1.58b)
D: 0.91 (Book Value of Equity 755.2m / Total Liabilities 830.5m)
Altman-Z'' = 5.61 = AAA

Beneish M -3.30

DSRI: 0.66 (Receivables 172.9m/231.9m, Revenue 891.6m/790.1m)
GMI: 0.94 (GM 39.31% / 41.73%)
AQI: 0.94 (AQ_t 0.53 / AQ_t-1 0.56)
SGI: 1.13 (Revenue 891.6m / 790.1m)
TATA: 0.01 (NI 104.6m - CFO 89.5m) / TA 1.59b)
Beneish M = -3.30 (Cap -4..+1) = AA

What is the price of SXI shares?

As of September 27, 2026, the stock is trading at USD 280.17 with a total of 147,783 shares traded. Over the past week, the price has changed by +7.26%, over one month by -8.06%, over three months by -17.06% and over the past year by +39.58%.

Current recommended Stop Loss: 260.90 (which is 6.9% or 2 ATR below the current price).

Is SXI a buy, sell or hold?

Standex International has received a consensus analysts rating of 4.40. Therefore, it is recommended to buy SXI.

StrongBuy: 2
Buy: 3
Hold: 0
Sell: 0
StrongSell: 0

What are the forecasts/targets for the SXI price?

Analysts Target Price	338.4	20.8%

Standex International (SXI) - Fundamental Data Overview as of 23 September 2026

Market Cap USD = 3.22b (3.22b USD * 1.0 USD.USD)
P/E Trailing = 30.278
P/E Forward = 27.027
P/S = 3.616
P/B = 4.2479
P/EG = 0.9516
Revenue TTM = 891.6m USD
EBIT TTM = 193.7m USD
EBITDA TTM = 232.3m USD
Long Term Debt = 518.0m USD (from longTermDebt, last quarter)
Short Term Debt = 12.5m USD (from shortTermDebt, two quarters ago)
Debt = 602.1m USD (from shortLongTermDebtTotal, last quarter) + Leases 48.3m
Net Debt = 423.4m USD (calculated: Debt 602.1m - CCE 178.7m)
Enterprise Value = 3.65b USD (3.22b + Debt 602.1m - CCE 178.7m)
Interest Coverage Ratio = 6.31 (Ebit TTM 193.7m / Interest Expense TTM 30.7m)
EV/FCF = 72.66x (Enterprise Value 3.65b / FCF TTM 50.2m)
FCF Yield = 1.38% (FCF TTM 50.2m / Enterprise Value 3.65b)
FCF Margin = 5.63% (FCF TTM 50.2m / Revenue TTM 891.6m)
Net Margin = 11.74% (Net Income TTM 104.6m / Revenue TTM 891.6m)
Gross Margin = 41.73% ((Revenue TTM 891.6m - Cost of Revenue TTM 519.6m) / Revenue TTM)
Gross Margin QoQ = 42.69% (prev 40.93%)
Tobins Q-Ratio = 2.30 (Enterprise Value 3.65b / Total Assets 1.59b)
Interest Expense / Debt = 5.10% (Interest Expense 30.7m / Debt 602.1m)
Taxrate = 21.02% (34.3m / 162.9m)
NOPAT = 152.9m (EBIT 193.7m * (1 - 21.02%))
Current Ratio = 2.40 (Total Current Assets 551.8m / Total Current Liabilities 229.5m)
Debt / Equity = 0.80 (Debt 602.1m / totalStockholderEquity, last quarter 755.2m)
Debt / EBITDA = 1.82 (Net Debt 423.4m / EBITDA 232.3m)
Debt / FCF = 8.43 (Net Debt 423.4m / FCF TTM 50.2m)
Total Stockholder Equity = 729.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.64% (Net Income 104.6m / Total Assets 1.59b)
RoE = 14.35% (Net Income TTM 104.6m / Total Stockholder Equity 729.3m)
RoCE = 15.53% (EBIT 193.7m / Capital Employed (Equity 729.3m + L.T.Debt 518.0m))
RoIC = 11.66% (NOPAT 152.9m / Invested Capital 1.31b)
WACC = 10.44% (E(3.22b)/V(3.83b) * Re(11.64%) + D(602.1m)/V(3.83b) * Rd(5.10%) * (1-Tc(0.21)))
Discount Rate = 11.64% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 85.18 | Cagr: 0.82%
[DCF] Terminal Value 71.51% ; FCFF base≈46.6m ; Y1≈53.4m ; Y5≈78.7m
[DCF] Fair Price = 35.87 (EV 863.9m - Net Debt 423.4m = Equity 440.5m / Shares 12.3m; r=10.44% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 95.05 | EPS CAGR: 9.92% | SUE: 1.24 | # QB: 1
Revenue Correlation: 85.71 | Revenue CAGR: 8.74% | SUE: 0.33 | # QB: 0
EPS current Quarter (2026-09-30): EPS=2.33 | Chg30d=+0.00% | Revisions=+29% | Analysts=5
EPS next Quarter (2026-12-31): EPS=2.39 | Chg30d=-0.75% | Revisions=+0% | Analysts=5
EPS current Year (2027-06-30): EPS=9.96 | Chg30d=+0.00% | Revisions=+12% | GrowthEPS=+14.0% | GrowthRev=+7.0%
EPS next Year (2028-06-30): EPS=11.86 | Chg30d=+0.00% | Revisions=+40% | GrowthEPS=+19.1% | GrowthRev=+8.7%
[Analyst] Revisions Ratio: +28% (up=10, down=5)